Ildong Pharmaceutical Co., Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ildong Pharmaceutical Co., Ltd.
Korea’s Key Words For 2023: Regulatory Innovation, Digital Healthcare
The Pink Sheet’s roundup of key regulatory issues in Korea for 2022 and outlook for this year.
Potential Milestone Year Ahead For Korean NASH Contenders
Scrip takes a look at key recent drug development activities in the NASH area by Korean firms, which are now pursuing the global development of their candidates as they look to leverage innovation to expand internationally.
World Bio Summit: Collaboration, Preparedness Key Words For Next Pandemic
The recent World Bio Summit in Seoul saw executives of global pharmas including Pfizer, Merck and Moderna discuss strategic approaches to advance the development of, and ensure equitable access to, vaccines, and also highlighted Korea’s potential role in ongoing global efforts.
Challenging Alzheimer's: Korean Firms Forge Ahead In Multiple Modalities
In Vivo takes an infographic look at where South Korea stands in the development of a wide-ranging set of drugs for Alzheimer’s disease and which companies are still in the challenging race.
- Medical Devices
- Generic Drugs
- OTC, Consumer
- Consumables, Central Supplies
- Implantable Devices
- Infection Control-Sterilization
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
- Radiofrequency Devices
- Rehabilitation Equipment and Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
Drug Discovery Tools
- Natural Products
- Molecular Diversity
- Drug Discovery Tools
- Other Names / Subsidiaries
- Idience Co., Ltd.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.